24 min listen
Diabetes Dialogue: April 2022
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: April 2022
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ratings:
Length:
19 minutes
Released:
Apr 28, 2022
Format:
Podcast episode
Description
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of semaglutide 2.0 mg (Ozempic)'s approval, the use of novel glycemic control metrics, and a preview of ATTD 2022.
Released:
Apr 28, 2022
Format:
Podcast episode
Titles in the series (94)
Subcutaneous Semaglutide for Weight Loss with Thomas Wadden, PhD by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives